Global Hospital-Acquired Infection (HAI) Diagnostic Scope and Market Size
Hospital-Acquired Infection (HAI) Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Infection (HAI) Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Molecular Diagnostics
Blood Tests
Urinalysis
Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
bioMérieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type1.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Molecular Diagnostics 1.2.3 Blood Tests 1.2.4 Urinalysis 1.3 Market by Application1.3.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Urinary Tract Infections 1.3.3 Pneumonia 1.3.4 Surgical Site Infections 1.3.5 Bloodstream Infections 1.3.6 Other Hospital Infections 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Perspective (2016-2027) 2.2 Hospital-Acquired Infection (HAI) Diagnostic Growth Trends by Regions2.2.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hospital-Acquired Infection (HAI) Diagnostic Historic Market Share by Regions (2016-2021) 2.2.3 Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Regions (2022-2027) 2.3 Hospital-Acquired Infection (HAI) Diagnostic Industry Dynamic2.3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Trends 2.3.2 Hospital-Acquired Infection (HAI) Diagnostic Market Drivers 2.3.3 Hospital-Acquired Infection (HAI) Diagnostic Market Challenges 2.3.4 Hospital-Acquired Infection (HAI) Diagnostic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue3.1.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue (2016-2021) 3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2016-2021) 3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hospital-Acquired Infection (HAI) Diagnostic Revenue 3.4 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio3.4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020 3.5 Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Area Served 3.6 Key Players Hospital-Acquired Infection (HAI) Diagnostic Product Solution and Service 3.7 Date of Enter into Hospital-Acquired Infection (HAI) Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Type 4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Type (2016-2021) 4.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Type (2022-2027) 5 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Application 5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Application (2016-2021) 5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027) 6.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type6.2.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) 6.2.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) 6.2.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027) 6.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application6.3.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) 6.3.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) 6.3.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027) 6.4 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country6.4.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) 6.4.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027) 7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type7.2.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) 7.2.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) 7.2.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027) 7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application7.3.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) 7.3.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) 7.3.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027) 7.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country7.4.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) 7.4.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027) 8.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type8.2.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027) 8.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application8.3.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027) 8.4 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region8.4.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027) 9.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type9.2.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) 9.2.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) 9.2.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027) 9.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application9.3.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) 9.3.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) 9.3.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027) 9.4 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country9.4.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) 9.4.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027) 10.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type10.2.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027) 10.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application10.3.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027) 10.4 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country10.4.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 bioMérieux11.1.1 bioMérieux Company Details 11.1.2 bioMérieux Business Overview 11.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.1.4 bioMérieux Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.1.5 bioMérieux Recent Development 11.2 Abbott Laboratories11.2.1 Abbott Laboratories Company Details 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.2.4 Abbott Laboratories Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.2.5 Abbott Laboratories Recent Development 11.3 Alere, Inc.11.3.1 Alere, Inc. Company Details 11.3.2 Alere, Inc. Business Overview 11.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.3.4 Alere, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.3.5 Alere, Inc. Recent Development 11.4 Roche11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.4.4 Roche Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Siemens Healthcare11.5.1 Siemens Healthcare Company Details 11.5.2 Siemens Healthcare Business Overview 11.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.5.4 Siemens Healthcare Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.5.5 Siemens Healthcare Recent Development 11.6 Becton Dickenson11.6.1 Becton Dickenson Company Details 11.6.2 Becton Dickenson Business Overview 11.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.6.4 Becton Dickenson Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.6.5 Becton Dickenson Recent Development 11.7 Cepheid Inc.11.7.1 Cepheid Inc. Company Details 11.7.2 Cepheid Inc. Business Overview 11.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.7.4 Cepheid Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.7.5 Cepheid Inc. Recent Development 11.8 Thermo Fisher Scientific11.8.1 Thermo Fisher Scientific Company Details 11.8.2 Thermo Fisher Scientific Business Overview 11.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.8.4 Thermo Fisher Scientific Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.8.5 Thermo Fisher Scientific Recent Development 11.9 Seegene, Inc.11.9.1 Seegene, Inc. Company Details 11.9.2 Seegene, Inc. Business Overview 11.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.9.4 Seegene, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.9.5 Seegene, Inc. Recent Development 11.10 Qiagen11.10.1 Qiagen Company Details 11.10.2 Qiagen Business Overview 11.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Introduction 11.10.4 Qiagen Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) 11.10.5 Qiagen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer
Summary: Get latest Market Research Reports on Hospital-Acquired Infection (HAI) Diagnostic. Industry analysis & Market Report on Hospital-Acquired Infection (HAI) Diagnostic is a syndicated market report, published as Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Hospital-Acquired Infection (HAI) Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 07 April, 2021